Literature DB >> 24333422

Inversed relationship between CD44 variant and c-Myc due to oxidative stress-induced canonical Wnt activation.

Go J Yoshida1, Hideyuki Saya2.   

Abstract

Cancer stem-like cells express high amount of CD44 variant8-10 which protects cancer cells from redox stress. We have demonstrated by immunohistochemical analysis and Western blotting, and reverse-transcription polymerase chain reaction, that CD44 variant8-10 and c-Myc tend to show the inversed expression manner in gastric cancer cells. That is attributable to the oxidative stress-induced canonical Wnt activation, and furthermore, the up-regulation of the downstream molecules, one of which is oncogenic c-Myc, is not easily to occur in CD44 variant-positive cancer cells. We have also found out that CD44v8-10 expression is associated with the turn-over of the c-Myc with the experiments using gastric cancer cell lines. This cannot be simply explained by the model of oxidative stress-induced Wnt activation. CD44v8-10-positive cancer cells are enriched at the invasive front. Tumor tissue at the invasive area is considered to be composed of heterogeneous cellular population; dormant cancer stem-like cells with CD44v8-10 (high)/ Fbw7 (high)/ c-Myc (low) and proliferative cancer stem-like cells with CD44v8-10 (high)/ Fbw7 (low)/ c-Myc (high).
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CD44 variant; Cancer stem-like cell; Fbw7; Gastric cancer; Redox stress-induced Wnt signal; c-Myc

Mesh:

Substances:

Year:  2013        PMID: 24333422     DOI: 10.1016/j.bbrc.2013.12.016

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  42 in total

1.  Establishment of a porcine pancreatic stem cell line using T-REx(™) system-inducible Wnt3a expression.

Authors:  Wei Han; Xin He; Mingzhi Zhang; Shuxian Hu; Fen Sun; Lipeng Ren; Jinlian Hua; Sha Peng
Journal:  Cell Prolif       Date:  2015-04-20       Impact factor: 6.831

2.  CD44 family proteins in gastric cancer: a meta-analysis and narrative review.

Authors:  Ying Wu; Zhi Li; Chenlu Zhang; Kai Yu; Zan Teng; Guoliang Zheng; Shuang Wang; Yunpeng Liu; Lei Cui; Xiaosong Yu
Journal:  Int J Clin Exp Med       Date:  2015-03-15

Review 3.  Targeting cancer stem cells from a metabolic perspective.

Authors:  Yao-An Shen; Siao-Cian Pan; I Chu; Ruo-Yun Lai; Yau-Huei Wei
Journal:  Exp Biol Med (Maywood)       Date:  2020-02-26

4.  Effectiveness of plasma treatment on gastric cancer cells.

Authors:  Koji Torii; Suguru Yamada; Kae Nakamura; Hiromasa Tanaka; Hiroaki Kajiyama; Kuniaki Tanahashi; Naoki Iwata; Mitsuro Kanda; Daisuke Kobayashi; Chie Tanaka; Tsutomu Fujii; Goro Nakayama; Masahiko Koike; Hiroyuki Sugimoto; Shuji Nomoto; Atsushi Natsume; Michitaka Fujiwara; Masaaki Mizuno; Masaru Hori; Hideyuki Saya; Yasuhiro Kodera
Journal:  Gastric Cancer       Date:  2014-07-06       Impact factor: 7.370

5.  Oxidative stress, epigenetics, and cancer stem cells in arsenic carcinogenesis and prevention.

Authors:  Lingzhi Li; Fei Chen
Journal:  Curr Pharmacol Rep       Date:  2016-01-23

6.  sE-cadherin serves as a diagnostic and predictive parameter in prostate cancer patients.

Authors:  Igor Tsaur; Kristina Thurn; Eva Juengel; Kilian M Gust; Hendrik Borgmann; Rene Mager; Georg Bartsch; Elsie Oppermann; Hanns Ackermann; Karen Nelson; Axel Haferkamp; Roman A Blaheta
Journal:  J Exp Clin Cancer Res       Date:  2015-05-14

Review 7.  Metabolic reprogramming: the emerging concept and associated therapeutic strategies.

Authors:  Go J Yoshida
Journal:  J Exp Clin Cancer Res       Date:  2015-10-06

8.  Dual role of CD44 isoforms in ampullary adenocarcinoma: CD44s predicts poor prognosis in early cancer and CD44ν is an indicator for recurrence in advanced cancer.

Authors:  Cheng-Lin Wu; Ying-Jui Chao; Ta-Ming Yang; Yi-Ling Chen; Kung-Chao Chang; Hui-Ping Hsu; Yan-Shen Shan; Ming-Derg Lai
Journal:  BMC Cancer       Date:  2015-11-16       Impact factor: 4.430

9.  Mutated in colorectal cancer (MCC) is a novel oncogene in B lymphocytes.

Authors:  Shanique K E Edwards; Jacqueline Baron; Carissa R Moore; Yan Liu; David H Perlman; Ronald P Hart; Ping Xie
Journal:  J Hematol Oncol       Date:  2014-09-09       Impact factor: 17.388

Review 10.  Pim kinases in hematological malignancies: where are we now and where are we going?

Authors:  Patrizia Mondello; Salvatore Cuzzocrea; Michael Mian
Journal:  J Hematol Oncol       Date:  2014-12-10       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.